It would appear that the five proliferation markers are sufficient for determining patient outcome, as these are the only genes with high HRs and are highly significant.
← all excerpts
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
1
—
—